169 related articles for article (PubMed ID: 35284775)
1. Epidemiology of cerebral venous sinus thrombosis and cerebral venous sinus thrombosis with thrombocytopenia in the United States, 2018 and 2019.
Payne AB; Adamski A; Abe K; Reyes NL; Richardson LC; Hooper WC; Schieve LA
Res Pract Thromb Haemost; 2022 Feb; 6(2):e12682. PubMed ID: 35284775
[TBL] [Abstract][Full Text] [Related]
2. High Incidence and Unique Features of Cerebral Venous Sinus Thrombosis in Hospitalized Patients With COVID-19 Infection.
McCullough-Hicks ME; Halterman DJ; Anderson D; Cohen K; Lakshminarayan K
Stroke; 2022 Sep; 53(9):e407-e410. PubMed ID: 35920155
[TBL] [Abstract][Full Text] [Related]
3. Baseline Characteristics and Readmissions after Cerebral Venous Sinus Thrombosis in a Nationally Representative Database.
Leavell Y; Khalid M; Tuhrim S; Dhamoon MS
Cerebrovasc Dis; 2018; 46(5-6):249-256. PubMed ID: 30602146
[TBL] [Abstract][Full Text] [Related]
4. Age-Stratified Risk of Cerebral Venous Sinus Thrombosis After SARS-CoV-2 Vaccination.
Krzywicka K; van de Munckhof A; Sánchez van Kammen M; Heldner MR; Jood K; Lindgren E; Tatlisumak T; Putaala J; Kremer Hovinga JA; Middeldorp S; Levi MM; Cordonnier C; Arnold M; Zwinderman AH; Ferro JM; Coutinho JM; Aguiar de Sousa D
Neurology; 2022 Feb; 98(7):e759-e768. PubMed ID: 34921101
[TBL] [Abstract][Full Text] [Related]
5. Incidence of thrombocytopenia-associated cerebral venous sinus thrombosis: a population-based study.
Mahadevan JJ; Psaltis PJ; Thrift AG; Kleinig TJ
BMJ Neurol Open; 2024; 6(1):e000605. PubMed ID: 38757112
[TBL] [Abstract][Full Text] [Related]
6. Cerebral Venous Sinus Thrombosis in Systemic Lupus Erythematosus.
Darmawan G; Hamijoyo L; Oehadian A; Bandiara R; Amalia L
Acta Med Indones; 2018 Oct; 50(4):343-345. PubMed ID: 30631001
[TBL] [Abstract][Full Text] [Related]
7. US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.
See I; Su JR; Lale A; Woo EJ; Guh AY; Shimabukuro TT; Streiff MB; Rao AK; Wheeler AP; Beavers SF; Durbin AP; Edwards K; Miller E; Harrington TA; Mba-Jonas A; Nair N; Nguyen DT; Talaat KR; Urrutia VC; Walker SC; Creech CB; Clark TA; DeStefano F; Broder KR
JAMA; 2021 Jun; 325(24):2448-2456. PubMed ID: 33929487
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Sánchez van Kammen M; Aguiar de Sousa D; Poli S; Cordonnier C; Heldner MR; van de Munckhof A; Krzywicka K; van Haaps T; Ciccone A; Middeldorp S; Levi MM; Kremer Hovinga JA; Silvis S; Hiltunen S; Mansour M; Arauz A; Barboza MA; Field TS; Tsivgoulis G; Nagel S; Lindgren E; Tatlisumak T; Jood K; Putaala J; Ferro JM; Arnold M; Coutinho JM; ; Sharma AR; Elkady A; Negro A; Günther A; Gutschalk A; Schönenberger S; Buture A; Murphy S; Paiva Nunes A; Tiede A; Puthuppallil Philip A; Mengel A; Medina A; Hellström Vogel Å; Tawa A; Aujayeb A; Casolla B; Buck B; Zanferrari C; Garcia-Esperon C; Vayne C; Legault C; Pfrepper C; Tracol C; Soriano C; Guisado-Alonso D; Bougon D; Zimatore DS; Michalski D; Blacquiere D; Johansson E; Cuadrado-Godia E; De Maistre E; Carrera E; Vuillier F; Bonneville F; Giammello F; Bode FJ; Zimmerman J; d'Onofrio F; Grillo F; Cotton F; Caparros F; Puy L; Maier F; Gulli G; Frisullo G; Polkinghorne G; Franchineau G; Cangür H; Katzberg H; Sibon I; Baharoglu I; Brar J; Payen JF; Burrow J; Fernandes J; Schouten J; Althaus K; Garambois K; Derex L; Humbertjean L; Lebrato Hernandez L; Kellermair L; Morin Martin M; Petruzzellis M; Cotelli M; Dubois MC; Carvalho M; Wittstock M; Miranda M; Skjelland M; Bandettini di Poggio M; Scholz MJ; Raposo N; Kahnis R; Kruyt N; Huet O; Sharma P; Candelaresi P; Reiner P; Vieira R; Acampora R; Kern R; Leker R; Coutts S; Bal S; Sharma SS; Susen S; Cox T; Geeraerts T; Gattringer T; Bartsch T; Kleinig TJ; Dizonno V; Arslan Y
JAMA Neurol; 2021 Nov; 78(11):1314-1323. PubMed ID: 34581763
[TBL] [Abstract][Full Text] [Related]
9. Cerebral Venous Sinus Thrombosis and Thrombotic Events After Vector-Based COVID-19 Vaccines: A Systematic Review and Meta-analysis.
Palaiodimou L; Stefanou MI; Katsanos AH; Aguiar de Sousa D; Coutinho JM; Lagiou P; Michopoulos I; Naska A; Giannopoulos S; Vadikolias K; Voumvourakis KI; Papaevangelou V; Vassilakopoulos TI; Tsiodras S; Tsivgoulis G
Neurology; 2021 Nov; 97(21):e2136-e2147. PubMed ID: 34610990
[TBL] [Abstract][Full Text] [Related]
10. HIT in the head: a systematic review of cerebral venous sinus thrombosis in classical and autoimmune heparin-induced thrombocytopenia.
Bauman MMJ; Naylor RM; Wijdicks EF
J Thromb Thrombolysis; 2021 Oct; 52(3):952-961. PubMed ID: 34089462
[TBL] [Abstract][Full Text] [Related]
11. Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination.
van de Munckhof A; Krzywicka K; Aguiar de Sousa D; Sánchez van Kammen M; Heldner MR; Jood K; Lindgren E; Tatlisumak T; Putaala J; Kremer Hovinga JA; Middeldorp S; Levi M; Arnold M; Ferro JM; Coutinho JM
Eur J Neurol; 2022 Jan; 29(1):339-344. PubMed ID: 34536256
[TBL] [Abstract][Full Text] [Related]
12. Positive Predictive Value of ICD-10 Codes for Cerebral Venous Sinus Thrombosis in Taiwan's National Health Insurance Claims Database.
Liao SC; Shao SC; Lai EC; Lin SJ; Huang WI; Hsieh CY
Clin Epidemiol; 2022; 14():1-7. PubMed ID: 35018122
[TBL] [Abstract][Full Text] [Related]
13. Mortality of cerebral venous-sinus thrombosis in a large national sample.
Borhani Haghighi A; Edgell RC; Cruz-Flores S; Feen E; Piriyawat P; Vora N; Callison RC; Alshekhlee A
Stroke; 2012 Jan; 43(1):262-4. PubMed ID: 21998058
[TBL] [Abstract][Full Text] [Related]
14. Clinical profile and outcome of cerebral venous sinus thrombosis at tertiary care center.
Patil VC; Choraria K; Desai N; Agrawal S
J Neurosci Rural Pract; 2014 Jul; 5(3):218-24. PubMed ID: 25002759
[TBL] [Abstract][Full Text] [Related]
15. Cerebral Venous Sinus Thrombosis Score and its Correlation with Clinical and MRI Findings.
Kalita J; Singh VK; Jain N; Misra UK; Kumar S
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104324. PubMed ID: 31422004
[TBL] [Abstract][Full Text] [Related]
16. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.
Krzywicka K; Heldner MR; Sánchez van Kammen M; van Haaps T; Hiltunen S; Silvis SM; Levi M; Kremer Hovinga JA; Jood K; Lindgren E; Tatlisumak T; Putaala J; Aguiar de Sousa D; Middeldorp S; Arnold M; Coutinho JM; Ferro JM
Eur J Neurol; 2021 Nov; 28(11):3656-3662. PubMed ID: 34293217
[TBL] [Abstract][Full Text] [Related]
17. Stroke Associated with COVID-19 Vaccines.
Kakovan M; Ghorbani Shirkouhi S; Zarei M; Andalib S
J Stroke Cerebrovasc Dis; 2022 Jun; 31(6):106440. PubMed ID: 35339857
[TBL] [Abstract][Full Text] [Related]
18. Decompressive surgery for malignant cerebral venous sinus thrombosis: a retrospective case series from Pakistan and comparative literature review.
Raza E; Shamim MS; Wadiwala MF; Ahmed B; Kamal AK
J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):e13-22. PubMed ID: 24119368
[TBL] [Abstract][Full Text] [Related]
19. An Observational Study to Evaluate the Effectiveness of Rivaroxaban in the Management of Cerebral Venous Sinus Thrombosis.
Fatima M; Asghar MS; Abbas S; Iltaf S; Ali A
Cureus; 2021 Mar; 13(3):e13663. PubMed ID: 33824814
[TBL] [Abstract][Full Text] [Related]
20. Nephrotic Syndrome May Be One of the Important Etiologies of Cerebral Venous Sinus Thrombosis.
Wang Y; Meng R; Duan J; Liu G; Chen J; Li S; Ji X
J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2415-22. PubMed ID: 27350124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
